Comparing survival and subsequent treatment of first-line tyrosine kinase inhibitors in patients of advanced lung adenocarcinoma with epidermal growth factor receptor mutation

Publication date: Available online 9 March 2021Source: Journal of the Formosan Medical AssociationAuthor(s): Ming-Yi Huang, Kun-Pin Hsieh, Ru-Yu Huang, Jen-Yu Hung, Li-Tzong Chen, Ming-Ju Tsai, Yi-Hsin Yang
Source: Journal of the Formosan Medical Association - Category: General Medicine Source Type: research